Deciding whether to get Botox can feel confusing, especially when marketing claims and results don't always match. That is ...

Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...

If over-the-counter options, prescription medications and lifestyle tweaks don’t solve the burping issues, patients can turn to Botox for a potential remedy, medical experts say. Whether it’s injected ...

A spa in Prior Lake, Minnesota, is at the center of a criminal investigation into alleged "black market" Botox.

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder ...

AstraZeneca's Imfinzi with BCG delivers 32% lower recurrence risk in high-risk bladder cancer. Read more here.

This is the first meta-analysis comparing the overall survival of patients with limited-stage small cell bladder cancer who underwent radical surgery with platinum-based perioperative chemotherapy vs ...

The investigation began in 2024, following a complaint filed with the Minnesota Department of Health and subsequently ...

Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...

Pharma titans Merck, Pfizer and Astellas Pharma are delivering an "enormous new hope" for patients with an aggressive form of ...